These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29802412)
21. Pitolisant: First Global Approval. Syed YY Drugs; 2016 Sep; 76(13):1313-1318. PubMed ID: 27438291 [TBL] [Abstract][Full Text] [Related]
22. Role of Histamine H Xu G; Liu N; Qiu Y; Qi J; Zhu D Stem Cells Dev; 2024 Feb; 33(3-4):67-78. PubMed ID: 38032751 [TBL] [Abstract][Full Text] [Related]
23. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice. Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428 [TBL] [Abstract][Full Text] [Related]
24. A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents. Dalbøge LS; Pedersen PJ; Hansen G; Fabricius K; Hansen HB; Jelsing J; Vrang N PLoS One; 2015; 10(8):e0135634. PubMed ID: 26266945 [TBL] [Abstract][Full Text] [Related]
25. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
26. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759 [TBL] [Abstract][Full Text] [Related]
27. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. Ríos-Lugo MJ; Cano P; Jiménez-Ortega V; Fernández-Mateos MP; Scacchi PA; Cardinali DP; Esquifino AI J Pineal Res; 2010 Nov; 49(4):342-8. PubMed ID: 20663045 [TBL] [Abstract][Full Text] [Related]
28. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Inocente C; Arnulf I; Bastuji H; Thibault-Stoll A; Raoux A; Reimão R; Lin JS; Franco P Clin Neuropharmacol; 2012; 35(2):55-60. PubMed ID: 22356925 [TBL] [Abstract][Full Text] [Related]
29. Anti-obesity and anti-inflammatory effects of synthetic acetic acid vinegar and Nipa vinegar on high-fat-diet-induced obese mice. Beh BK; Mohamad NE; Yeap SK; Ky H; Boo SY; Chua JYH; Tan SW; Ho WY; Sharifuddin SA; Long K; Alitheen NB Sci Rep; 2017 Jul; 7(1):6664. PubMed ID: 28751642 [TBL] [Abstract][Full Text] [Related]
30. Triphala and its constituents ameliorate visceral adiposity from a high-fat diet in mice with diet-induced obesity. Gurjar S; Pal A; Kapur S Altern Ther Health Med; 2012; 18(6):38-45. PubMed ID: 23251942 [TBL] [Abstract][Full Text] [Related]
31. Anti-obesity effects of boiled tuna extract in mice with obesity induced by a high-fat diet. Kim Y; Kwon MJ; Choi JW; Lee MK; Kim C; Jung J; Aprianita H; Nam H; Nam TJ Int J Mol Med; 2016 Oct; 38(4):1281-8. PubMed ID: 27498820 [TBL] [Abstract][Full Text] [Related]
32. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys. Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903 [TBL] [Abstract][Full Text] [Related]
33. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Pang Z; Wu NN; Zhao W; Chain DC; Schaffer E; Zhang X; Yamdagni P; Palejwala VA; Fan C; Favara SG; Dressler HM; Economides KD; Weinstock D; Cavallo JS; Naimi S; Galzin AM; Guillot E; Pruniaux MP; Tocci MJ; Polites HG Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481 [TBL] [Abstract][Full Text] [Related]
34. Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease. Abegg K; Bernasconi L; Hutter M; Whiting L; Pietra C; Giuliano C; Lutz TA; Riediger T Diabetes Obes Metab; 2017 Dec; 19(12):1740-1750. PubMed ID: 28544245 [TBL] [Abstract][Full Text] [Related]
35. Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity. Dudek M; Marcinkowska M; Bucki A; Olczyk A; Kołaczkowski M Metab Brain Dis; 2015 Dec; 30(6):1487-94. PubMed ID: 26419385 [TBL] [Abstract][Full Text] [Related]
36. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. Després JP; Golay A; Sjöström L; N Engl J Med; 2005 Nov; 353(20):2121-34. PubMed ID: 16291982 [TBL] [Abstract][Full Text] [Related]
37. Comparison of potential preventive effects of pomegranate flower, peel and seed oil on insulin resistance and inflammation in high-fat and high-sucrose diet-induced obesity mice model. Harzallah A; Hammami M; Kępczyńska MA; Hislop DC; Arch JR; Cawthorne MA; Zaibi MS Arch Physiol Biochem; 2016; 122(2):75-87. PubMed ID: 26822470 [TBL] [Abstract][Full Text] [Related]
38. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629 [TBL] [Abstract][Full Text] [Related]
39. Anti-obesity Effect of Halophyte Crop, Limonium tetragonum in High-Fat Diet-Induced Obese Mice and 3T3-L1 Adipocytes. Kim NH; Heo JD; Rho JR; Yang MH; Jeong EJ Biol Pharm Bull; 2017; 40(11):1856-1865. PubMed ID: 29093332 [TBL] [Abstract][Full Text] [Related]
40. Anti-Obesity Effects of the Mixture of Eriobotrya japonica and Nelumbo nucifera in Adipocytes and High-Fat Diet-Induced Obese Mice. Sharma BR; Oh J; Kim HA; Kim YJ; Jeong KS; Rhyu DY Am J Chin Med; 2015; 43(4):681-94. PubMed ID: 26133751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]